Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 12.0B | 10.9B | 11.0B | 11.8B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 3.0B | 3.1B | 2.9B | 3.0B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 3.4B | 3.5B | 4.3B | 5.2B |
| Tax provision | 916.3M | 657M | 929.9M | 1.2B |
| Net income | 2.5B | 2.8B | 3.4B | 4.0B |
| Basic EPS | — | 7.5 | 8.9 | 10.6 |
| Diluted EPS | — | 7.5 | 8.9 | 10.6 |
| Basic average shares | — | 377.6M | 377.8M | 377.4M |
| Diluted average shares | — | 378.6M | 378.6M | 378.8M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |